Dr. Jordan answers the question: 'How can I be estrogen receptor-positive?' — -- Question: How can my breast cancer be estrogen receptor-positive when I am postmenopausal and my body is losing ...
A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in breast cancer treatment, making immunotherapy effective against the most common ...
12don MSN
Why some breast cancers evade treatment: Protein secreted by T cells may explain resistant tumors
Up to 20% of hormone receptor-positive breast cancers don't respond to antiestrogen therapies. A study led by researchers at ...
Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery This open-label, parallel-group trial randomly assigned 132 participants to receive camizestrant 75, 150, or 300 ...
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study POSITIVE is a prospective trial ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive results from the Phase III evERA study evaluating ...
Aromatase inhibitors (AIs) are a cornerstone of adjuvant therapy for hormone receptor–positive breast cancer, significantly reducing recurrence and mortality. However, by suppressing estrogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results